Correction: Teprotumumab: A Review in Thyroid Eye Disease

被引：0
|
作者：
Tina Nie
Yvette N. Lamb
机构：
[1] Springer Nature,
来源：
Drugs | 2022年 / 82卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1757 / 1757
相关论文
共 50 条
  • [31] The role of teprotumumab in chronic, clinically active thyroid eye disease
    Yu, Caroline Y.
    Simmons, Brittany A.
    Pham, Chau M.
    Shriver, Erin M.
    EYE, 2022, 36 (07) : 1500 - 1501
  • [32] Proptosis Regression After Teprotumumab Treatment for Thyroid Eye Disease
    Rosenblatt, Tatiana R.
    Chiou, Carolina A.
    Yoon, Michael K.
    Wolkow, Natalie
    Lee, Nahyoung Grace
    Freitag, Suzanne K.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 40 (02): : 187 - 191
  • [33] Outcomes of Patients With Thyroid Eye Disease Partially Treated With Teprotumumab
    Ho, Tiffany C.
    Maamari, Robi N.
    Kossler, Andrea L.
    Sears, Connie M.
    Freitag, Suzanne K.
    Reshef, Edith R.
    Shinder, Roman
    Rootman, Daniel B.
    Diniz, Stefania B.
    Kahana, Alon
    Schlachter, Dianne
    Do, Thai H.
    Kally, Peter
    Turner, Sara
    Mokhtarzadeh, Ali
    Harrison, Andrew R.
    Hwang, Christopher J.
    Kim, Hee Joon
    Avila, Sarah A.
    Thomas, Dilip A.
    Magazin, Maja
    Wester, Sara T.
    Lee, Wendy W.
    Clauss, Kevin D.
    Holds, John B.
    Sniegowski, Matthew
    Compton, Christopher J.
    Briggs, Christian
    Malik, Amina I.
    Lucarelli, Mark J.
    Burkat, Cat N.
    Patel, Luv G.
    Couch, Steven M.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2023, 39 (02): : 150 - 155
  • [34] Refractory Thyroid Eye Disease Unresponsive to Teprotumumab: A Case Report
    Singh, Gurdeep
    Taylor, Brittany
    Michalek, Samantha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [35] Teprotumumab in thyroid eye disease: wonder drug or great divider?
    Perros, Petros
    Hegedus, Laszlo
    EUROPEAN THYROID JOURNAL, 2023, 12 (04)
  • [36] Facial and Eyelid Changes in Thyroid Eye Disease Are Reversed by Teprotumumab
    Ugradar, Shoaib
    Braun, Jenna
    Wang, Yao
    Zimmerman, Erin
    Douglas, Raymond S.
    PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2021, 9 (09) : E3809
  • [37] Teprotumumab for thyroid eye disease: early response is not required for benefit
    Shoaib Ugradar
    Yao Wang
    Tunde Mester
    George J. Kahaly
    Raymond S. Douglas
    Eye, 2022, 36 : 1403 - 1408
  • [38] Evaluation of the efficacy, safety, and durability of teprotumumab in thyroid eye disease
    Mechels, Keegan
    Hwang, Catherine
    Perry, Julian
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [39] Perspective on the Current Role of Teprotumumab in Treatment of Thyroid Eye Disease
    Allen, Richard C.
    Bradley, Elizabeth A.
    Fante, Robert G.
    Lucarelli, Mark J.
    OPHTHALMOLOGY, 2021, 128 (08) : 1125 - 1128
  • [40] Reactivation After Teprotumumab Treatment for Active Thyroid Eye Disease
    Hwang, Catherine J.
    Rebollo, Nicole P.
    Mechels, Keegan B.
    Perry, Julian D.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2024, 263 : 152 - 159
12345